Trial reportDrug design, development and therapy2026
Analgesic Efficacy and Motor-Sparing Properties of Superior Trunk Block versus Interscalene Brachial Plexus Block with Liposomal Bupivacaine for Shoulder Arthroscopy: A Randomized Controlled Trial.
Trial report in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The interscalene brachial plexus block (ISB) is widely regarded as the most commonly used regional anesthesia technique for perioperative analgesia in arthroscopic shoulder surgery; however, it is associated with a high incidence of phrenic nerve paresis and profound, often complete, motor blockade of the upper extremity. In contrast, the superior trunk block (STB) represents an anatomically targeted alternative specifically designed to preserve distal motor function while maintaining effective surgical anesthesia. This randomized comparative study evaluated the motor-sparing profile of an identical liposomal bupivacaine-based admixture administered via either STB or ISB, as well as their comparative analgesic effects. Patients and Methods: In this prospective, randomized, participant- and outcome-assessor-blinded, active-controlled trial, 68 patients undergoing elective arthroscopic shoulder surgery were randomly assigned to receive either ultrasound-guided ISB (n = 35) or STB (n = 33). Both groups received a 20 mL admixture containing 10 mL of liposomal bupivacaine (133 mg) and 10 mL of 0.9% normal saline. The primary outcomes were postoperative pain intensity measured by the visual analogue scale (VAS; range 0-10 cm) at rest and during activity at 30 min, 6 h, 12 h, and 24 h. Secondary outcomes included the modified Bromage scale (MBS; range 0-4) for upper extremity motor function (assessed by shoulder abduction, elbow flexion, and elbow extension) and the University of California at Los Angeles (UCLA) shoulder score (range 2-35) for early functional assessment at 24 h. No block-related complications were observed in either group. Results: No statistically significant differences were observed in either resting or activity VAS scores between the two groups at any postoperative time points (all Conclusion: Ultrasound-guided superior trunk block with a liposomal bupivacaine admixture provides postoperative analgesia comparable to the traditional interscalene approach, with no statistically significant differences in VAS scores observed between the two groups. Crucially, the superior trunk approach offers a significant clinical advantage by preserving upper extremity motor function, making it an optimized regional anesthetic technique aligned with modern enhanced recovery after surgery (ERAS) principles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.